Myriad Genetics Files $250 Million Offering
Myriad Genetics
(MYGN) - Get Myriad Genetics Inc. Report
filed with the
Securities and Exchange Commission
Scroll to Continue
TheStreet Recommends
to sell up to $250 million of securities.
The Salt Lake City company makes diagnostic equipment and develops drugs using gene analysis.
Myriad's stock closed down $2.09 Friday at $49.91.
